Longevity Leaders World Congress Transparent 140x
The Life Lab

Biotech and Age Tech Showcases

Innovation is at the core of the longevity market, and we’re delighted to showcase some of the most exciting emerging biotech and Age Tech platforms in development. Across two days, thirty visionary entrepreneurs will present their work in The Life Lab: Biotech and Age Tech Showcases. Applications are now closed and are currently being assessed by two expert Selection Committees of investors and end-users. Full programme will be released 25th February 2020.

Supported by:
Benchmark 300x150

Discover novel platforms in Age Tech and longevity biotech

Compare emerging business models and market potential

Designed to help you source new investment opportunities


Biotech Showcase

The Biotech Showcase is for investors looking for new opportunities in longevity. Presenting companies are developing novel technologies within:

• Cell senescence
• Gene therapy
• DNA methylation and epigenetics
• Biomarker discovery
• Protein degradation
• Plasma proteomics
• Cancer
• Alzheimer’s disease and dementia
• Parkinson’s disease
• Mitochondria function
• Stem cells or regenerative medicine
• Systems biology and AI applications
• mTOR regulation
• Telomere function
• Metabolomics
• Cardiovascular disease
• Autoimmune diseases
• Inflammation

Biotech Showcase Selection Committee

Laurence Barker, CCBO, DDF, SV Health Managers LLP

Laurence Barker

SV Health Investors
Alexandra Bause, Co-Founder, Apollo Ventures

Alexandra Bause

Apollo Ventures
Chas Bountra, Chief Scientist, SGC Oxford

Chas Bountra

Chief Scientist
SGC Oxford
Mark Hammond, Founding Partner, Deep Science Ventures

Mark Hammond

Founding Partner
Deep Science Ventures
Fiona de Hemptine, Venture Partner, UCB ventures

Fiona de Hemptine

Venture Partner
UCB ventures
Xinhong Lim, Director, Vickers Venture Partners

Xinhong Lim

Vickers Venture Partners
Natalia Novac, Director, Emerging Technology & Innovation, Eli Lilly & Company

Natalia Novac

Director, Emerging Technology & Innovation
Eli Lilly & Company
Alexandra Tolia, Partner, Fund+

Alexandra Tolia


Life Lab Age Tech Showcase

The Age Tech Showcase is for investors and end-users looking for novel technology facilitating “ageing well” including:

• Incontinence
• Menopause
• Loss of sight or hearing
• Back pain
• Sexual health
• Nutrition
• Anti-fraud
• Financial planning
• Legacy planning
• Housing
• Insurance
• At-home care
• Appliances
• Re-education
• Mobility
• Communication
• Social & leisure

Life Lab Selection Committee

Phil Baylis, CEO of Later Living, Legal & General Capital

Phil Baylis

CEO of Later Living
Legal & General Capital
Yael Benvenisti, CEO, Mediterranean Towers Ventures

Yael Benvenisti

Mediterranean Towers Ventures
Rachel Carey, Chief Scientist, Zinc

Rachel Carey

Chief Scientist
Dominic Endicott, Partner, 4GEN Ventures

Dominic Endicott

4GEN Ventures
Tom Grape, Chairman & CEO, Benchmark Senior Living

Tom Grape

Chairman & CEO
Benchmark Senior Living
Lorraine Morley, Project Lead, Age Tech, Allia & Age Tech Accelerator 300x

Lorraine Morley

Project Lead, Age Tech
Allia & Age Tech Accelerator
Deepali Nangia, Early Stage Adviser & Angel Investor

Deepali Nangia

Early Stage Adviser & Angel Investor
Heather Roxborough, Partner, Optum Ventures

Heather Roxborough

Optum Ventures
Jonathan Synett, Chief Investment Officer, NCL Technology Ventures

Jonathan Synett

Chief Investment Officer
NCL Technology Ventures
Max Zamkow, Managing Partner, Third Act Ventures

Max Zamkow

Managing Partner
Third Act Ventures